Browse > Article

The effects of high-dose intravenous immunoglobulin on plasma protein and lipid levels in the patients with Kawasaki disease  

Lee, Keun Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Dong-Un (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Hyun Seung (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Jang, Pil Sang (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Young-Hoon (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Jin Tack (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Hyun Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Kyung-Yil (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Joon-Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.12, 2006 , pp. 1348-1353 More about this Journal
Abstract
Purpose : The reticuloendothelial system is composed of sinusoidal capillaries, through which even large protein molecules are freely movable between plasma and interstitial space, including the lymphatic system. Therefore, high-dose intravenous immunoglobulin (IVIG) would cause a redistribution of proteins between two compartments. To investigate this hypothesis, we measured plasma protein and lipid levels in patients with Kawasaki disease before and after high-dose IVIG treatment. Methods : Thirty four children with Kawasaki disease who had complete responses to high-dose IVIG treatment (1 g/kg/day for two consecutive days), were analyzed. Before and after the administration of IVIG, serum analyses were performed for such parameters as total protein, albumin, ${\gamma}$-globulins (IgG, IgM, IgA), ${\alpha}1-$, ${\alpha}2-$, and ${\beta}-$ globulin fractions, and lipid profiles (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglyceride). Results : The levels of ${\gamma}$-globulins including IgG, IgM, IgA were significantly increased, and IgG was increased by $1,779{\pm}304mg/dL$ after two-dose of IVIG infusion. The levels of albumin, ${\alpha}1-$, ${\alpha}2-$, and ${\beta}$ globulin fractions were significantly decreased by 18 percent, 24 percent, 19 percent and 12 percent, respectively. HDL-cholesterol level was significantly decreased by 20 percent, while LDL-cholesterol and triglyceride levels were significantly increased by 21 percent and 50 percent, respectively. The total cholesterol level was not changed. Conclusion : High-dose IVIG treatment decreased the levels of a variety of proteins except immunoglobulins, and the increase of IgG after IVIG treatment was lower than expected. Our results suggest that a part of infused IVIG and plasma proteins, including etiologic proteins for Kawasaki disease, may be distributed to the extravascular compartments. The rapid improvement of symptoms induced by IVIG in Kawasaki disease might be explained by this mode of action of IVIG.
Keywords
Intravenous immunoglobulin; Mucocutaneous lymph node syndrome; Plasma protein; Plasma lipid;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33.   DOI   ScienceOn
2 Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations; Assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997;20:1102-7   DOI   ScienceOn
3 Lobo ED, Hansen RJ, Balthasar JP. Antibody phamokinetics and pharmacodynamics. J Pharm Sci 2004;93:2645-8   DOI   ScienceOn
4 Clarlton B, Schindhelm K, Smeby LC, Farrell PC. Analysis of immunoglobulin G kinetics in the non-steady state. J Lab Clin Med 1985;105:312-20
5 Galli E, Barbieri C, Cantani A, Solano A, Longhi MA, Businco L. Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow up. Ann Allergy 1990;64: 147-50
6 Greenbaum LA. Electrolyte and acid base disorders. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson Textbook of Pediatrics. 17th ed. Philadelphia : Saunders 2004:191-242
7 Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res 1997;42:651-5   DOI   ScienceOn
8 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
9 Goodsell DS, Olson AJ. Soluble proteins : Size, shape and function. Trends Biochem Sci 1993;18:65-8   DOI   ScienceOn
10 Shulman ST. IVGG therapy in Kawasaki disease: mechanism(s) of action. Clin Immunol Immunopathol 1989;53:S141-6   DOI   ScienceOn
11 Chiang AN, Hwang B, Shaw GC, Lee BC, Lu JH, Meng CC, Chou P. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. Clin Chim Acta 1997;260:15-26   DOI   ScienceOn
12 Mitra A, Singh S, Devidayal, Khullar M. Serum lipids in north indian children treated for Kawasaki Disease. Int Heart J 2005;46:811-7   DOI
13 Marcinkiewicz J, Szymanowska Z, Mazurrek A. Immunoregulatory mechansims of action of intravenous gammaglobulin in Kawasaki syndrome. Przegl Lek 1998;55:611-3
14 Newberger JW, Takahashi M, Beiser AS, Burns JC, Chung KJ, Melish ME: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991;324:1633-9   DOI   ScienceOn
15 Leung DY. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous globulin. Clin Exp Immunol 1996;104:49-54
16 Ross MH, Romrell LJ, Kaye GI. Histology : A text and atlas. 3rd ed. Baltimore : Williams & Wilkins, 1995:310-11
17 Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1970;76;333-7
18 Toubi E, Etzioni A. Intravenous immunoglobulin in immunodeficiency states: state of the art. Clin Rev Allergy Immunol 2005;29:167-72   DOI   ScienceOn
19 Okada T, Harada K, Okuni M. Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease(acute mucocutaneous lymph node syndrome). Jpn Circ J 1982;46:1039-44   DOI   ScienceOn
20 Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2(8411):1055-8
21 Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985;56:846-51   DOI   ScienceOn
22 Rader DJ, Hobbs HH. Disorders of lipoprotein metabolism. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of Internal Medicine. 16th ed. McGraw-Hill Companies, Inc. 2005: 2286-98
23 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110:2747-71   DOI   ScienceOn
24 Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patient. J Pediatr 1999;134:589-96   DOI   ScienceOn
25 Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysm in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 1975;86: 892-8   DOI
26 Lee KY, Han JW, Lee JS, Whang KT. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Paediatr 2002; 91:64-7